CClinicalTrials.gg
TerminatedNCT01647477DEREDIAUpdated Mar 13, 2026

Interventional Study Collecting Quantitative and Qualitative Data About Patient With Non Treated Cancer

An interventional study of interview and questionnaires in Upper Aerodigestive Tract Cancer, sponsored by Centre Oscar Lambret. Terminated at 6 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-13.

Sponsored by Centre Oscar Lambret · Not applicable, Interventional, and Prevention

Why this study was terminated
lack of enrollment
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to determine the impact of sociocognitive and emotional factors on the time of the initial consult

Read the detailed description

identify wich sociocognitive factors influence the delay to go to a doctor after the emergence of first symptoms

02

Conditions studied

  • Upper Aerodigestive Tract Cancer

Browse trials for

Keywords

  • non treated cancer
  • oral cavity
  • oropharynx
  • hypopharynx
  • larynx
  • first consultation
03

In context

Laryngeal Diseases

136 studies on the registry are indexed under Laryngeal Diseases; 23 are open to participants now.

This study's enrollment of 90 is above the median of 41 across 111 interventional studies indexed under Laryngeal Diseases.

Browse Laryngeal Diseases studies →

Lead sponsor

Centre Oscar Lambret is the lead sponsor of 127 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • age ≥ 18 years
  • oral cavity cancer, oropharynx cancer, hypopharynx cancer, larynx cancer
  • non treated cancer
  • patient informed of his diagnosis
  • speak fluent french
  • patient covered by health insurance
  • signed informed consent

Inclusion Criteria for "interviewed " patients :

  • no speech troubles
  • patient consents being recorded

Exclusion Criteria:

  • history of cancer
  • psychological history
  • patient under guardianship
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (actual)

Study arms

  • Active comparator
    questionnaires

    4 questionnaires to answer at baseline 45 minutes approx.

    Behavioral: questionnaires

  • Experimental
    interview

    semi directive interview 105 patients

    Behavioral: interview · Behavioral: questionnaires

Interventions

  • Behavioralinterview

    25 minutes of semi directive interview

  • Behavioralquestionnaires

    questionnaires to answer at baseline 45 minutes

06

What researchers measure

Primary outcomes

  1. time of first consultation

    median time between date of symptoms appearance and date of first consultation

    Time frame: baseline

Secondary outcomes

  1. identify variables associated with time of consultation

    medical data : medical history, symptoms, entry into care pathway sociodemographic and emotional indicators

    Time frame: baseline

07

Study locations

6 sites
  • Centre Hospitalier
    Boulogne-sur-Mer, 62 231, France
  • Oscar Lambret Center
    Lille, 59 020, France
  • Centre Hospitalier Régional et Universitaire - Hopital HURIEZ
    Lille, 59 037, France
  • La Louviere Hospital
    Lille, 59 042, France
  • Gray Center
    Maubeuge, 59 600, France
  • Centre Médical Spécialisé du Littoral
    Saint-Martin-Boulogne, 62280, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01647477
Lead sponsor
Centre Oscar Lambret
Responsible party
Sponsor
First posted
Jul 23, 2012
Start date
Dec 2012
Primary completion
Oct 2014
Completion
Feb 2017
Last update
Mar 13, 2026

Study contacts

Veronique CHRISTOPHE, MDPhD
study director · Lille 3 University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion